This study aimed to evaluate the COVID-19 hospitalizations in a tertiary hospital by age group and month, considering the introduction and the advance of the vaccination against the disease. The laboratory-confirmed COVID-19-associated hospitalizations among people aged 20 years or older, that occurred between March 2020 and June 2021, were distributed by month of symptom onset and age group. The proportion of hospitalizations by age group was calculated for the year 2021. The proportions were compared using the chi-square test for trends. The marks of vaccination advances among different age groups were taken from the official website LocalizaSUS. In 2020, hospitalizations among people aged 60-80 years old were the most frequent (39.1%). From January-June 2021, when the vaccination commenced, while hospitalizations of patients aged 20 to < 40 and 40 to 60 years old showed an increasing trend, the older age groups and those with vaccination recommendations (from 60 to < 80 and from 80 or over) showed a downward trend. As of June 2021, with widespread vaccination, a drop in hospitalizations was observed in > 60 years old. At 20 to <40 and 40 to < 60, an increase in hospitalizations was observed. It demonstrates the important role of vaccination in combating the COVID-19 pandemic.

Historically, men tend to neglect their health, especially with regard to seeking health care services which may be either due to incompatibility between working hours and the hours of health establishments or for cultural reasons.The Blue November campaign emerges as an attempt to raise awareness among men regarding the need for prevention of examinations, vaccines when recommended, and the development of a healthy lifestyle with a balanced diet, reduction in alcohol intake and smoking, and the regular practice of physical exercise 1 . However, the Blue November became limited as the period of combating prostate cancer with the determination of PSA alone without considering other factors in the development of this disease that should be interpreted before and after this examination. The interpretation of the PSA level should be performed together with other data, such as sexual activity, the practice of sports, prostate infection, and benign prostate enlargement 2 .The PSA level can contribute to the diagnosis provided that risk factors, symptoms, and variations in the PSA over time are also analyzed. This examination and its interpretation could avoid unnecessary procedures, such as prostate biopsy in a patient with high PSA alone 2,3 .Limiting Blue November to the determination of PSA level alone could further contribute to the exclusion of men to access to integral health care 4 . We should use this campaign as a period to encourage the culture of care, regular medical appointments, disease prevention, and the promotion of healthy habits, with a consequent improvement in individual and social quality of life.The culprit here is not the PSA examination, but its isolated use as a representative of male health. The clinical assessment, digital rectal examination, and PSA together can improve the quality of the diagnosis.

Background Implantation of the double-J stent is a common procedure in urology. The function of this device is to maintain the flow of urine from the ureteropelvic junction to the urinary bladder when the ureter is blocked or partially blocked for some reason. Once in place, the stent may cause low back pain, hematuria, symptoms of urinary irritation, a reduction in labor capacity, infection and calcification which are side effects that are easy to manage. However, severe complications can occur, such as the insertion of the stent into the circulatory system, such as the vena cava, which, although uncommon, is one of the most severe and difficult to manage. This work reports the case of a patient with the accidental insertion of a double-J stent into the inferior vena cava. Case Description An 80-year-old female patient with repeated urinary tract infections using a double-J stent due to stenosis of the right distal ureter distal presenting retroperitoneal fibrosis secondary to previous radiotherapy. The patient had Lynch syndrome, ovarian and uterine cancer, colorectal cancer, and nephrolithiasis. She had been submitted to multiple previous surgeries. Due to the possibility of viral infection by coronavirus disease 2019 (COVID-19), chest computed tomography was performed, which suggested the insertion of the double-J stent in the inferior vena cava, confirmed by abdominal computed tomography. As the distal end of the stent was within the bladder, the decision was made to remove the stent by cystoscopy, with the implantation of a new stent using fluoroscopic control for the confirmation of its trajectory. No intraoperative or postoperative complications occurred and the patient is currently in outpatient follow-up. Conclusions Situations such as this require caution during the implantation of the drainage device, with the occurrence of resistance indicating the need to discontinue the procedure and perform a new assessment with imaging exams. No intraoperative or postoperative complications occurred and the patient is currently in outpatient follow-up.